Skip to main content
Livermore
Livermore
ZHEN

Arcutis Biotherapeutics, Inc.

ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001787306

In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.

Politicians who traded ARQT

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
6
Filings
6
Members
2
Buys / sells
4 / 2
Estimated volume
$48.0K
Sum of range midpoints
Politicians who traded ARQT
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Gilbert Ray Cisneros, Jr. House · CA32 / 1$24.0KMay 29, 2026Jun 8, 2026
Josh Gottheimer House · NJ32 / 1$24.0KSep 15, 2023Oct 15, 2023

Trades

Reported trades in Arcutis Biotherapeutics, Inc., newest filings first.

Politician trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Gilbert Ray Cisneros, Jr. House · CAARQTArcutis Biotherapeutics, Inc. - Common stockBuySelfMay 29, 2026Jun 8, 202610 days$1K-$15KFiling
Gilbert Ray Cisneros, Jr. House · CAARQTArcutis Biotherapeutics, Inc. - Common stockBuySelfMar 3, 2026Apr 7, 202635 days$1K-$15KFiling
Gilbert Ray Cisneros, Jr. House · CAARQTArcutis Biotherapeutics, Inc. - Common stockSell (partial)SelfDec 11, 2025Jan 12, 202632 days$1K-$15KFiling
Josh Gottheimer House · NJARQTArcutis Biotherapeutics, Inc. - Common stockSellJointSep 15, 2023Oct 15, 202330 days$1K-$15KFiling
Josh Gottheimer House · NJARQTArcutis Biotherapeutics, Inc. - Common stockBuyJointApr 17, 2023May 19, 202332 days$1K-$15KFiling
Josh Gottheimer House · NJARQTArcutis Biotherapeutics, Inc. - Common stockBuyJointJun 15, 2022Jul 22, 202237 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.